The Pot Report. Get the Report
The week in cannabis, in five minutes.Free, every week, from The Pot Report.
Get the Report

Home / States / District of Columbia

Legal

Is cannabis legal in District of Columbia?

Partly. Adults 21 and older can legally possess up to 2 ounces, grow a few plants at home and give small amounts away in D.C., but there are no licensed recreational stores and selling is illegal. Legal sales happen only through the medical cannabis program, which adults 21+ (including visitors) can join by self-certifying.

Last checked November 11, 2026 · Information, not legal advice

At a glance
Recreational useAdults 21+ may possess 2 oz or less, use it on private property, grow at home and give away up to 1 oz with no payment or exchange. There are no licensed recreational sales, and selling any amount is a crime.
Medical useLegal. D.C. residents of any age can register (21+ may self-certify; 20 and under need a healthcare practitioner's recommendation and minors need a caregiver). Non-residents 21+ can self-certify for a temporary registration, and patients from many other state programs can buy with their home-state card. Patients may buy up to 8 oz in a rolling 30-day period.
Possession limitAdults 21+: 2 oz or less. Registered medical patients may purchase up to 8 oz per rolling 30 days.
Home growingAllowed for adults 21+: up to 6 plants within your residence, no more than 3 of them mature.
Where to buyOnly ABCA-licensed medical cannabis retailers (more than 70 physical and online), which serve registered patients showing a patient registration and government photo ID. There are no licensed recreational stores; ABCA advises checking that a shop is on its official map and displays its license.
Public useIllegal. Smoking, eating or drinking marijuana in public - including any street, sidewalk, alley, park or parking area - is a criminal violation, and medical patients can also be arrested for public use. Federal law still prohibits possession, and federal officers may arrest people for it in D.C.
DrivingOperating a vehicle or boat under the influence of marijuana is a crime. The police guidance describes an impairment-based rule and gives no numeric THC limit.
Crossing state linesMarijuana remains illegal under federal law. TSA says it does not search for marijuana, but if it is found during airport screening officers must refer the matter to law enforcement.

What’s legal, what isn’t

You can

  • Possess 2 oz or less of marijuana and use it on private property if you are 21 or older.
  • Grow up to 6 plants (3 mature) inside your residence.
  • Self-certify as a medical cannabis patient if you are 21 or older (free for D.C. residents; visitors pay $10-$100 for a temporary registration) and buy from licensed medical retailers.

You can’t

  • Sell any amount of marijuana, or receive payment or any goods or services in exchange for it.
  • Smoke, eat or drink marijuana in public, including on streets, sidewalks, alleys, parks or parking areas.
  • Possess more than 2 oz, or drive a vehicle or operate a boat under the influence of marijuana.

The medical program

  1. Who qualifies: No list of qualifying conditions. D.C. residents of any age: 21+ self-certify; 20 and under need a healthcare practitioner's recommendation; minors need an adult caregiver. Non-residents must be 21+ and self-certify. Patients 21+ enrolled in a recognized program in about 40 other states/territories can buy with their home registration and photo ID (Virginia patients need their written certification).
  2. How to apply: Apply online through the ABCA customer portal (MyABCA.DC.Gov) with a government-issued photo ID; D.C. residents also upload proof of residency. Residents get a temporary digital registration immediately (valid 90 days), followed by a two-year registration after staff review; visitor registrations are digital and usable immediately. Official application
  3. What it costs: D.C. residents: digital registration and renewal fees are currently waived (standard fee otherwise $100, reduced $25, for 2 years); a physical card costs $10. Non-residents: $10 (3 days), $20 (30 days), $50 (90 days), $75 (180 days) or $100 (365 days). No practitioner visit is needed for self-certifying adults 21+.

What’s changing

  • D.C. Act 26-391, Medical Cannabis Licensing and Unlicensed Establishment Enforcement Clarification Emergency Amendment Act of 2026 - extends conditional licenses to 3 years, revises retailer distance rules and expands ABCA's power to close shops selling Schedule I substances
    Signed July 30, 2026 as a 90-day emergency act (ABCA says in effect until Oct. 28, 2026); status of any temporary or permanent successor not confirmed as of Nov. 9, 2026
  • MyABCA.DC.gov - new online portal for patient and caregiver registrations replaces the legacy system
    Launched Aug. 18, 2026; registrations filed in the old system before 8 a.m. that day still process there
  • Ongoing ABCA/MPD closures of unlicensed cannabis retailers
    Enforcement continuing; most recent ABCA announcement Oct. 30, 2026

Latest from District of Columbia

All District of Columbia news
Laws · District of Columbia · November 16, 2026

Cannabis Regulatory Confusion and Its Impact on Consumer Adoption. – EBSCO

A study in the American Business Law Journal examines cannabis regulatory confusion and how it shapes consumer adoption. Authors Stephanie Geiger-Oneto and Robert Sprague say U.S. rules are inconsistent: marijuana stays Schedule I federally, yet eleven states and D.C. had legalized recreational use and thirty-six states and D.C. allowed medical use by the end of 2020.

Why it matters: The research suggests mixed legal signals do more than confuse; they may keep cannabis a stigmatized product even as legal access grows. For consumers and patients, that means the federal-state conflict can shape how legitimate the products seem, and how comfortable people feel buying them, not just whether purchases are legal.

Read moreSource: ebsco.com

Laws · District of Columbia, Maryland, Virginia · November 15, 2026

IgniteIt Brings the Cannabis Industry Back to Washington

IgniteIt's Capital & Policy Summit returns to the Grand Hyatt Washington on Wednesday, November 18, for its second Washington, D.C. edition. Congresswoman Dina Titus is set to discuss what follows rescheduling. Panels cover hemp, Virginia's coming market, capital markets and M&A, with regulators from Virginia, Maryland and D.C. on the bill.

Why it matters: The lineup shows where the industry expects the next fights: life after rescheduling, the hemp loophole as a congressional extension runs out December 11, and new mid-Atlantic markets. For consumers and patients, those debates shape future product availability, hemp-derived product rules and how regional markets take form. Nothing is decided at the event itself.

Read moreSource: Ganjapreneur

Laws · District of Columbia, New Mexico · November 15, 2026

Senate Panel Proposes Extending State Medical Marijuana Protections, Without House’s Anti-Rescheduling Provision

The Senate Appropriations Committee wants to keep the federal medical marijuana rider that shields state programs from Justice Department interference. Its Fiscal Year 2027 spending bill leaves out the House's ban on funding rescheduling. The committee also wants briefings on cannabis seizures from state-legal businesses and a report on illegal grows tied to foreign nationals.

Why it matters: Patients in state programs would keep the funding shield that has restrained federal prosecutors since 2014, so the Senate draft signals no change there. Dropping the House's rescheduling block leaves the administration's Schedule III effort unobstructed by this bill. Nothing is final, though: no votes are scheduled, and the House and Senate versions differ.

Read moreSource: Marijuana Moment

Laws · District of Columbia · November 12, 2026

DEA rejects cannabis business registrations in multiple states (Newsletter: November 12, 2026)

The DEA has sent orders rejecting medical cannabis businesses that sought federal registration and protections under rescheduling, according to Marijuana Moment. The rejections cover at least six states and Washington, D.C., and the agency raised various objections to those jurisdictions' marijuana laws. The DEA rejects cannabis registrations at a moment when the Trump administration is moving to reschedule marijuana.

Why it matters: Rescheduling was expected to give licensed medical cannabis businesses a path to federal registration and its protections. Rejections in several jurisdictions suggest that path may depend on how closely local rules match federal objections. For patients, that raises uncertainty about whether the supply chains serving their state or district programs will gain federal standing soon.

Read moreSource: Marijuana Moment

Next door

The rules change at the state line.